A High Cholesterol in Someone Over Seventy-Five
The question here is not whether the number is high but what treating it would buy, and the answer depends heavily on whether there is already established heart or artery disease. Where there is, the case for treatment stays strong at any age. Where there is not, the evidence thins considerably, and the decision becomes a genuine conversation about what someone wants, not a threshold to be met.
The pattern on your report
- Total cholesterol High Key
- LDL cholesterol High Key
- HDL cholesterol Normal Key
- eGFR Low Key
Printed as: eGFR in mL/min/1.73m2— Determines which treatments are appropriate and at what dose, and it declines with age in most people.HDL cholesterol in mmol/Lor mg/dLLDL cholesterol in mmol/Lor mg/dLTotal cholesterol in mmol/Lor mg/dL— Becomes less predictive of individual risk with age, while established disease becomes more so.
Why the numbers look like this
Cholesterol contributes to arterial disease over decades, so the benefit of lowering it accumulates slowly. Trials in younger adults show the difference emerging over years, which means someone has to live long enough for the treatment to pay off.
That arithmetic changes with age in two directions at once. Absolute risk rises steeply with age, so the same proportional reduction prevents more events per hundred people treated. But the time available for the benefit to accumulate shortens, and competing causes of death become more likely to arrive first.
Where disease is already present, the arithmetic resolves clearly. Events in that group are frequent and near-term, so the benefit arrives quickly and the evidence in older adults is much stronger.
Where it is not, the trials have included fewer people of this age and the results are correspondingly less certain, which is why guidelines describe this as a decision to be shared, not a rule to apply.
One further consideration belongs here. Cholesterol falling on its own in an older adult, with no treatment started, is not good news. It accompanies frailty, weight loss, poor nutrition and undiagnosed illness, and it is worth explaining, not welcoming.
Not being flagged is not the same as normal
Risk calculators are not validated at the upper end of the age range, and above a certain age they simply return a high result for almost everyone because age dominates the calculation. That makes a calculated percentage close to meaningless here, and it is one reason the conversation shifts from thresholds to preferences. The lipid values themselves also become less predictive of individual risk with age, while the presence of established disease becomes more so.
What else on the report can hide this
Establish first whether there is existing cardiovascular disease. A previous heart attack, stroke, angina, stent, bypass or peripheral arterial disease moves this from a discussion into a clear indication.
Where someone is already on treatment and tolerating it, continuing is usually the right default, since stopping removes an established benefit for no gain.
Kidney function and the full medication list matter more with age, because interactions and accumulation both become likelier and because muscle side effects are more common and more consequential when a fall is the result.
Frailty and life expectancy belong in the conversation explicitly, not by implication. Someone with several years of good function ahead is in a different position from someone in the last months of a long illness, and pretending otherwise helps nobody.
A falling cholesterol with no treatment change deserves a look, not a tick. Weight loss, poor intake, a new cancer and hyperthyroidism all lower it, and it is the direction of travel that carries the information.
What usually causes it
Listed from most to least common — not from most to least serious.
- Very common
Lifelong raised cholesterol
Present for decades. The question is what treating it now achieves, which depends on whether disease is already established.
- Very common
Established cardiovascular disease
A previous heart attack, stroke, stent or peripheral arterial disease. This moves treatment from a discussion into a clear indication at any age.
- Common
An underactive thyroid
Common at this age, raises cholesterol, and is easily corrected. Worth excluding before treating the lipids as primary.
- Common
Reduced kidney function
Alters both the lipid pattern and which treatments are appropriate at what dose.
- Common
Medication
Thiazides, steroids and others shift the panel, and polypharmacy is the norm at this age.
- Common
Weight gain or reduced activity
Contributes, though the scope for change is different from that in a younger person.
- Common
A falling cholesterol with no treatment
Not this pattern but the one to notice alongside it. Frailty, weight loss, poor nutrition and undiagnosed illness all lower it, and it warrants explaining.
- Uncommon
Familial hypercholesterolemia
Someone who has reached this age with it untreated has already demonstrated something about their individual risk, though relatives still benefit from testing.
- Uncommon
Protein loss through the kidney
A marked rise with a low albumin. The kidney is the finding, and the cholesterol follows it.
What is usually checked next
- Establish whether cardiovascular disease is already present The most important branch. With it, the case for treatment stays strong at any age.
- TSH Common at this age, raises cholesterol, and is easier to correct than the lipids themselves.
- Kidney function and a full medication review Interactions and accumulation both become likelier with age, and muscle side effects matter more when a fall is the consequence.
- A frank conversation about frailty and priorities Risk calculators are not validated at this age, so preferences carry more weight than a calculated percentage.
- An explanation for any fall in cholesterol A drop with no treatment change accompanies frailty, weight loss and undiagnosed illness.
When to seek care sooner
- Emergency Weakness or numbness on one side, or difficulty speaking
- Same day Chest pain or breathlessness on exertion
- Same day Severe muscle pain and weakness on a statin
- Soon Unintentional weight loss with a falling cholesterol
- Soon Repeated falls since starting or increasing a medicine
- Soon Calf pain on walking that stops on resting
Questions worth bringing to your appointment
- Do I already have heart or artery disease?
- What would treatment realistically prevent, and over how long?
- Has my thyroid been checked?
- If I am already on a statin and tolerating it, should I continue?
- My cholesterol has fallen without any change — should that be looked into?